| Literature DB >> 32961265 |
Maria Azparren-Angulo1, Felix Royo2, Esperanza Gonzalez1, Marc Liebana1, Bruno Brotons1, Jesús Berganza3, Felipe Goñi-de-Cerio3, Nicoló Manicardi4, Laia Abad-Jordà4, Jordi Gracia-Sancho5, Juan M Falcon-Perez6.
Abstract
Since the first descriptions of hepatocyte-released exosome-like vesicles in 2008, the number of publications describing Extracellular Vesicles (EVs) released by liver cells in the context of hepatic physiology and pathology has grown exponentially. This growing interest highlights both the importance that cell-to-cell communication has in the organization of multicellular organisms from a physiological point of view, as well as the opportunity that these circulating organelles offer in diagnostics and therapeutics. In the present review, we summarize systematically and comprehensively the myriad of works that appeared in the last decade and lighted the discussion about the best opportunities for using EVs in liver disease therapeutics.Entities:
Keywords: Diagnostics; EVs; Exosomes; Liver disease; Microvesicles; Therapeutics
Mesh:
Year: 2020 PMID: 32961265 DOI: 10.1016/j.pharmthera.2020.107683
Source DB: PubMed Journal: Pharmacol Ther ISSN: 0163-7258 Impact factor: 12.310